These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21364977)

  • 1. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.
    Francis SM; Chakrabarti S; Dick FA
    PLoS One; 2011 Feb; 6(2):e16434. PubMed ID: 21364977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development.
    Francis SM; Bergsied J; Isaac CE; Coschi CH; Martens AL; Hojilla CV; Chakrabarti S; Dimattia GE; Khoka R; Wang JY; Dick FA
    Mol Cell Biol; 2009 Aug; 29(16):4455-66. PubMed ID: 19506017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
    Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
    Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
    Talluri S; Francis SM; Dick FA
    PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
    Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
    Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis.
    Fifield BA; Vusich J; Haberfellner E; Andrechek ER; Porter LA
    Breast Cancer Res; 2024 Jun; 26(1):106. PubMed ID: 38943151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
    PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA resection protein CtIP promotes mammary tumorigenesis.
    Reczek CR; Shakya R; Miteva Y; Szabolcs M; Ludwig T; Baer R
    Oncotarget; 2016 May; 7(22):32172-83. PubMed ID: 27058754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.
    van Bragt MP; Hu X; Xie Y; Li Z
    Elife; 2014 Nov; 3():e03881. PubMed ID: 25415051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
    Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
    Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
    Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
    Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW; Wagner KU; Hennighausen L
    Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma.
    Bascom JL; Fata JE; Hirai Y; Sternlicht MD; Bissell MJ
    Cancer Res; 2005 Oct; 65(19):8617-21. PubMed ID: 16204027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
    McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
    Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.